European guidelines for sclerotherapy in chronic venous disorders

Phlebology

Volumn 29, Issue 6, 2014, Pages 338-354

  Rabe, E ^a   Breu, F X ^b   Cavezzi, A ^c   Smith, P Coleridge ^d   Frullini, A ^e   Gillet, J L ^f   Guex, J J ^g   Hamel Desnos, C ^h   Kern, P ⁱ   Partsch, B ^j   Ramelet, A A ^k   Tessari, L ^l   Pannier, F ^m  

^a UNIVERSITY OF BONN   (Germany)

^b Practice for Vascular Medicine   (Germany)

^c Poliambulatorio Hippocrates and Clinic Stella Maris   (Italy)

^d British Vein Institute   (United Kingdom)

^e Studio Medico Flebologico Figline Valdarno   (Italy)

^f Vascular Medicine and Phlebology   (France)

^g Cabinet de Phlebologie   (France)

^h Saint Martin Private Hospital   (France)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^j Private Practice   (Austria)

^k UNIVERSITY OF BERN   (Switzerland)

^l Bassi Foundation Trieste   (Italy)

^m UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

Chronic venous disease; foam sclerotherapy; sclerotherapy; varicose veins

Indexed keywords

POLIDOCANOL; TETRADECYL SULFATE SODIUM; MACROGOL DERIVATIVE; SCLEROSING AGENT;

ANAPHYLACTIC SHOCK; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPRESSION STOCKING; DEEP VEIN THROMBOSIS; EVIDENCE BASED PRACTICE; FOAM; HEADACHE; HEMATOMA; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; MEDICAL LITERATURE; METALLIC TASTE; MIGRAINE; NAUSEA; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SAPHENOUS VEIN; SCLEROTHERAPY; SKIN PIGMENTATION; SPEECH DISORDER; TELANGIECTASIA; TISSUE NECROSIS; TRANSIENT ISCHEMIC ATTACK; VALSALVA MANEUVER; VARICOSIS; VEIN DISEASE; VENOUS PRESSURE; VISUAL DISORDER; CHRONIC DISEASE; EUROPE; FEMALE; MALE; MEDICAL SOCIETY; PROCEDURES; STANDARDS; VARICOSE VEINS;

CHRONIC DISEASE; EUROPE; FEMALE; HUMANS; MALE; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SOCIETIES, MEDICAL; SODIUM TETRADECYL SULFATE; VARICOSE VEINS;

EID: 84902158618     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1177/0268355513483280     Document Type: Article

References (148)

1. Guyatt G,Gutterman D,Baumann MHet al.Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force.Chest. 2006;129:174-81.
2. Drake LA,Dinehart SM,Goltz RWet al.Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins.J Am Acad Dermatol. 1996;34:523-8.
3. Rabe E,Pannier-Fischer F,Gerlach Het al.Guidelines for sclerotherapy of varicose veins.Dermatol Surg. 2004;30:687-93.
4. Hamel-Desnos C,Ouvry P,Benigni JPet al.Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. 'The 3/1 Study'.Eur J Vasc Endovasc Surg. 2007;34:723-9.
5. Chen C-H,Chiu C-S,Yang C-H.Ultrasound-guided foam sclerotherapy for treating incompetent great saphenous veins - results of 5 years of analysis and morphologic evolvement study.Dermatol Surg. 2012;38:851-7.
6. Hamel-Desnos C,Desnos P,Wollmann JC,Quvry P,Mako S,Allaert FA.Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the long saphenous vein: Initial results.Dermatol Surg. 2003;29:1170-5.
7. Alos J,Carreno P,Lopez JAet al.Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial.Eur J Vasc Endovasc Surg. 2006;31:101-7.
8. Ouvry P,Allaert FA,Desnos P,Hamel-Desnos C.Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicenter randomised controlled trial with a 2-year follow-up.Eur J Vasc Surg. 2008;36:366-70.
9. Rabe E,Otto J,Schliephake D,Pannier F.Efficacy and Safety of Great Saphenous Vein Sclerotherapy Using Standardised Polidocanol Foam (ESAF): a randomised controlled multicentre clinical trial.Eur J Endovasc Vasc Surg. 2008;35:238-45.
10. Rasmussen LHet al.Randomized clinical trial comparing endovenous laser ablation,radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins.Br J Surg. 2011;98:1079-87.
11. Shadid N,Ceulen R,Nelemans Pet al.Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein.Br J Surg. 2012;99:1062-70.
12. Myers KA,Jolley D,Clough A,Kirwan J.Outcome of Ultrasound-guided Sclerotherapy for Varicose Veins: Medium-term Results Assessed by Ultrasound Surveillance.Eur J Vasc Endovasc Surg. 2007;33:116-21.
13. Zhang J,Jing Z,Schliephake DE,Otto J,Malouf GM,Gu YQ.Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study).Phlebology. 2012;27:184-90.
14. Guex JJ.Ultrasound guided sclerotherapy (USGS) for perforating veins.Hawaii Med J. 2000;59:261-2.
15. Masuda EM,Kessler DM,Lurie F,Puggioni A,Kistner RL,Eklof B.The effect of ultrasound guided sclerotherapy of incompetent perforator veins on venous clinical severity scores.J Vasc Surg. 2006;43:551-6.
16. Van Neer P,Veraart JCJM,Neumann H.Posterolateral thigh perforator varicosities in 12 patients: a normal deep venous system and successful treatment with ultrasound-guided sclerotherapy.Dermatol Surg. 2006;32:1346-52.
17. Kahle B,Leng K.Efficacy of sclerotherapy in varicose veins - a prospective, blinded placebocontrolled study.Dermatol Surg. 2004;30:723-8.
18. Norris MJ,Carlin MC,Ratz JL.Treatment of essential telangiectasias: Effects of increasing concentrations of polidocanol.J Am Acad of Dermatol. 1989;20:643-9.
19. Rabe E,Schliephake D,Otto J,Breu FX,Pannier F.Sclerotherapy of telangiectasias and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).Phlebology. 2010;25:124-31.
20. Uncu H.Sclerotherapy: a study comparing polidocanol in foam and liquid form.Phlebology. 2010;25:44-9.
21. Peterson JD,Goldman MP,Weiss RAet al.Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.Dermatol Surg. 2012;38:1-9.
22. Kakkos SK,Bountouroglou DG,Azzam M,Kalodiki E,Daskalopoulos M,Geroulakos G.Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.Journal of Endovascular Therapy. 2006;13:357-64.
23. McDonagh B,Sorenson S,Gray Cet al.Clinical spectrum of recurrent postoperative varicose veins and efficacy of sclerotherapy management using the compass technique.Phlebology. 2003;18:173-86.
24. Coleridge Smith P.Chronic venous disease treated by ultrasound guided foam sclerotherapy.Eur J Vasc Endovasc Surg. 2006;32:577-83.
25. Coleridge Smith P.Sclerotherapy and foam sclerotherapy for varicose veins.Phlebology. 2009;24:260-9.
26. Bradbury AW,Bate G,Pang K,Darvall KA,Adam DJ.Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux.J Vasc Surg. 2010;52:939-45.
27. Darvall KA,Bate GR,Adam DJ,Silverman SH,Bradbury AW.Duplex ultrasound outcomes following ultrasound guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins.Eur J Vasc Endovasc Surg. 2011;42:107-14.
28. Sukovatykh BS,Rodionov OA,Sukovatykh MB,Khodykin SP.Diagnosis and treatment of atypical forms of varicose disease of pelvic veins.Vestn Khir Im II Grek. 2008;167:43-5.
29. Paraskevas P.Successful ultrasound-guided foam sclerotherapy for vulval and leg varicosities secondary to ovarian vein reflux: a case study.Phlebology. 2011;26:29-31.
30. Stücker M,Reich S,Hermes Net al.Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with Phenprocoumon.JDDG. 2006;4:734-8.
31. De Waard MM,Der Kinderen DJ.Duplex ultrasonography-guided foam sclerotherapy of incompetent perforator veins in a patient with bilateral venous leg ulcers.Dermatol Surg. 2005;31:580-3.
32. Hertzman PA,Owens R.Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy.Phlebology. 2007;22:34-9.
33. Pang KH,Bate GR,Darvall KAL,Adam DJ,Bradbury AW.Healing and recurrence rates following ultrasound guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration.Eur J Vasc endovasc Surg. 2010;40:790-5.
34. Yamaki T,Nozaki M,Sasaki K.Color duplex-guided sclerotherapy for the treatment of venous malformations.Dermatol Surg. 2000;26:323-8.
35. Yamaki T,Nozaki M,Sakurai Het al.Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.J Vasc Surg. 2008;47:578-84.
36. Blaise S,Charavin-Cocuzza M,Riom Het al.Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.Eur J Vasc Endovasc Surg. 2011;41:412-7.
37. Kern P,Ramelet A-A,Wutschert R,Bounameaux H,Hayoz D.Single blind randomized study comparing chromated glycerin, polidocanol solution and polidocanol foam for treatment of telangiectactic leg veins.Dermatol Surg. 2004;30:367-72.
38. Rabe E,Pannier F,Gerlach H,Breu FX,Guggenbichler S,Wollmann JC.Leitlinie Sklerosierungsbehandlung der Varikose.Phlebologie. 2008;37:27-34.
39. Rao J,Wildemore JK,Goldmann MP.Double-blind prospective comparative trial between foamed and liquid polidocanol and natrium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.Dermatol Surg. 2005;31:631-5.
40. Bullens-Goessens YIJM,Mentink LFet al.Ultrasound-guided sclerotherapy of the insufficient short saphenous vein.Phlebologie Germany. 2004;33:89-91.
41. Schultz-Ehrenburg U,Tourbier H.Doppler-kontrollierte Verödungsbehandlung der Vena saphena magna.Phlebol u Proktol. 1984;13:117-22.
42. Vin F.Principes de la Sclérothéraphie des Troncs Saphènes Internes.Phlébologie. 1997;50:229-34.
43. Gohel MS,Epstein DM,Davies AH.Cost-effectiveness of traditional and endovenous treatments for varicose veins.Br J Surg. 2010;97:1815-23.
44. Wright D,Gobin JP,Bradbury AWet al.Varisolve European Phase III Investigators Group. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial.Phlebology. 2006;21:180-90.
45. Cavezzi A,Frullini A,Ricci S,Tessari L.Treatment of varicose veins by foam sclerotherapy: two clinical series.Phlebology. 2002;17:13-8.
46. Hamel-Desnos C,Ouvry P,Desnos Pet al.Sclérothérapie et thrombophilie: Démarche pour un consensus dans la sclérothérapie chez les thrombophiles.Phlébologie. 2003;56:165-69.
47. Breu FX,Guggenbichler S,Wollmann JC.2nd European Consensus Meeting on Foam Sclerotherapy, 28-30 April 2006, Tegernsee, Germany.Vasa. 2008;37 (Suppl. 71): 1-32.
48. Guex JJ.Les contre-indications de la sclérothérapie, mise à jour 2005.J Mal Vasc. 2005;30:144-9.
49. Hamel-Desnos CM,Gillet J-L,Desnos PR,Allaert FA.Sclerotherapy of varicose veins in patients with documented thrombophilia: a prospective controlled randomized study of 105 cases.Phlebology. 2009;24:176-82.
50. Gachet G,Spini L.Sclérothérapie des varices sous anticoagulants.Phlébologie. 2002;55:41-4.
51. Rathbun S,Norris A,Stoner J.Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders.Phlebology. 2012;27:105-17.
52. Guex JJ,Allaert F-A,Gillet J-L.Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions.Dermatol Surg. 2005;31:123-8.
53. Guex JJ.Complications of sclerotherapy: an update.Dermatol Surg. 2010;36:1056-63.
54. Munavalli GS,Weiss RA.Complications of sclerotherapy.Semin Cutan Med Surg. 2007;26:22-8.
55. Weiss RA,Weiss MA.Incidence of side effects in the treatment of telangiectasiastelangiectasias by compression sclerotherapy: hypertonics saline vs. polidocanol.J Dermatol Surg Oncol. 1990;16:800-4.
56. Gillet JL,Guedes JM,Guex JJet al.Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients.Phlebology. 2009;24:131-8.
57. Cavezzi A,Parsi K.Complications of foam sclerotherapy.Phlebology. 2012;27 (Suppl 1): 46-51.
58. Sarvananthan T,Shepherd AC,Willenberg T,Davies AH.Neurological complications of sclerotherapy for varicose veins.J Vasc Surg. 2012;55:243-51.
59. Feied CF,Jackson JJ,Bren TSet al.Allergic reactions to polidocanol for vein sclerosis.J Dermatol Surg Oncol. 1994;20:466-8.
60. Pradalier A,Vincent D,Hentschel Vet al.Allergie aux sclérosants des varices.Rev Fr Allergol. 1995;35:440-3.
61. Oesch A,Stirnemann P,Mahler F.The acute ischemic syndrome of the foot after sclerotherapy of varicose veins.Schweiz Med Wochenschr. 1984;114:1155-8.
62. Grommes J,Franzen EL,Binnebösel Met al.Inadvertent arterial injection using catheter-assisted sclerotherapy resulting in amputation.Dermatol Surg. 2010;37:536-8.
63. Goldman MP,Sadick NS,Weiss RA.Cutaneous necrosis, telangiectatic matting and hyperpigmentation following sclerotherapy.Dermatol Surg. 1995;21:19-29.
64. Schuller-Petrović S,Brunner F,Neuhold N,Pavlović MD,Wölkart G.Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy.JEADV. 2011;25:983-6.
65. Bergan JJ,Weiss RA,Goldman MP.Extensive tissue necrosis following high concentration sclerotherapy for varicose veins.Dermatol Surg. 2000;26:535-42.
66. Bihari I,Magyar É.Reasons for ulceration after injection treatment of telangiectasia.Dermatol Surg. 2001;27:133-6.
67. Geukens J,Rabe E,Bieber T.Embolia cutis medicamentosa of the foot after sclerotherapy.Eur J Dermatol. 1999;9:132-3.
68. Ramelet AA,Parmentier L.Delayed Nicolau's Livedoid dermatitis after ultrasound-guided sclerotherapy.Dermatol Surg. 2010;36:155-8.
69. Van der Plas JPL,Lambers JC,van Wersch JW,Koehler PJ.Reversible ischaemic neurological deficit after sclerotherapy of varicose veins.Lancet. 1994;343:428-428.
70. Künzelberger B,Pieck C,Altmeyer P,Stücker M.Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol.Derm Surg. 2006;32:1410-1410.
71. Parsi K.Paradoxical embolism, stroke and sclerotherapy.Phlebology. 2012;27:147-67.
72. Parsi K.Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications.Phlebology. 2011;26:140-7.
73. Morrison N,Cavezzi A,Bergan J,Partsch H.Regarding 'stroke after varicose vein foam injection sclerotherapy'.J Vasc Surg. 2006;44:224-5.
74. Passariello F. Sclerosing foam and patent foramen ovale. The final report. In: Word Congress of the International Union of Phlebology; 2007 Jun 18-20; Kyoto, Japan. Int Angiol 2007;26:87.
75. Wagdi P.Migräne und offenes Foramen Ovale: nur ein vorübergehender Hoffnungsschimmer?.Kardiovasc Med. 2006;9:32-6.
76. Gillet JL,Donnet A,Lausecker M,Guedes JM,Guex JJ,Lehmann P.Pathophysiology of visual disturbances occurring after foam sclerotherapy.Phlebology. 2010;25:261-6.
77. Frullini A,Felice F,Burchielli S,Di Stefano R.High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy.Phlebology. 2011;26:203-8.
78. Frullini A,Barsotti MC,Santoni T,Duranti E,Burchielli S,Di Stefano R.Significant endothelin release in patients treated with foam sclerotherapy.Dermatol Surg. 2012;38:741-7.
79. Yamaki T,Nozaki M,Sakurai Het al.Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.Eur J Endovasc Surg. 2008;37:343-8.
80. Forlee MV,Grouden M,Moore DJ,Shanik G.Stroke after varicose vein foam injection sclerotherapy.J Vasc Surg. 2006;43:162-4.
81. Busch RG,Derrick M,Manjoney D.Major neurological events following foam sclerotherapy.Phlebology. 2008;23:189-92.
82. Leslie-Mazwi TM,Avery LL,Sims JR.Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy.Neurocrit Care. 2009;11:97-100.
83. De Laney MC,Bowe CT,Higgins GLIII.Acute stroke from air embolism after leg Sclerotherapy.West J Emerg Med. 2010;11:397-397.
84. Ma RWL,Pilotelle A,Paraskevas P,Parsi K.Three cases of stroke following peripheral venous interventions.Phlebology. 2011;26:280-4.
85. Harzheim M,Becher H.Klockgether: Brain infarct from a paradoxical embolism following a varices operation.Dtsch Med Wochenschr. 2000;125:794-6.
86. Caggiati A,Franceschini M.Stroke following endovenous laser treatment of varicose veins.J Vasc Surg. 2010;51:218-20.
87. Gillet JL.Neurological complications of foam sclerotherapy: fears and reality.Phlebology. 2011;26:277-9.
88. Deichman B,Blum G.Cerebrovascular accident after sclerotherapy.Phlebologie. 1995;24:148-52.
89. Kas A,Begue M,Nifle C,Gil R,Neau JP.Infarctus cérébelleux après sclérothérapie de varicosités des membres inférieurs.Presse Med. 2000;29:1935-1935.
90. Hanisch F,Müller T,Krivocuca M,Winterholler M.Stroke following variceal sclerotherapy.Eur J Med Res. 2004;9:282-4.
91. Picard C,Deltombe B,Duru C,Godefroy O,Bugnicourt JM.Foam sclerotherapy: a possible cause of ischaemic stroke?.J Neurol Neurosurg Psychiatry. 2010;81:582-3.
92. Hahn M,Shulz T,Juenger M.Late stroke after foam sclerotherapy.VASA. 2010;39:108-10.
93. Guex JJ.Thombotic complications of the varicose disease.J Dermatol Surg. 1996;22:378-82.
94. Hamel-Desnos C,Desnos P,Ferré B,Le Querrec A.In vivo biological effects of foam sclerotherapy.Eur J Vasc Endovasc Surg. 2011;42:238-45.
95. Fabi SG,Peterson JD,Goldman MP,Guiha I.An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins.Dermatol Surg. 2012;38:367-72.
96. Jia X,Mowatt G,Burr JM,Cassar K,Cooke J,Fraser C.Systematic review of foam sclerotherapy for varicose veins.Br J Surg. 2007;94:925-36.
97. Myers KA,Jolley D.Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose vein.Eur J Vasc Endovasc Surg. 2008;36:602-5.
98. Zipper SG.Nervus peronäus-Schaden nach Varizensklerosierung mit Aethoxysklerol.Versicherungsmedizin. 2000;4:185-7.
99. Reich-Schupke S,Weyer K,Altmeyer P,Stücker M.Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5% foam.Vasa. 2010;39:169-74.
100. Georgiev MJ.Postsclerotherapy hyperpigmentations: a one-year follow-up.Dermatol Surg Oncol. 1990;16:608-10.
101. Scultetus AH,Villavicencio JL,Kao TCet al.Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial.J Vasc Surg. 2003;38:896-903.
102. Ramelet A-A. Phlébologie esthétique. Télangiectasies: possibilités thérapeutiques. Cosmétologie et Dermatologie esthétique. Paris: EMC (Elsevier Masson SAS, Paris), 2010.
103. Morrison N,Neuhardt DL,Rogers CRet al.Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation.J Vasc Surg. 2008;47:830-6.
104. Morrison N,Neuhardt DL,Rogers CRet al.Incidence of side effects using carbon dioxide oxygen foam for chemical ablation of superficial veins of the lower extremity.Eur J Vasc Endovasc Surg. 2010;40:407-13.
105. Beckitt T,Elstone A,Ashley S.Air versus physiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins.Eur J Vasc Endovasc Surg. 2011;42:115-9.
106. Hessel G,Breu FX,Kuschmann A,Hartmann K,Salomon N.Sclerotherapy using air- or CO2-O2-foam: post-approval study.Phlebologie. 2012;41:77-88.
107. Mercer KG,Scott DJ,Berridge DC.Preoperative duplex imaging is required before all operations for primary varicose veins.Br J Surg. 1998;85:1495-7.
108. Blomgren L,Johansson G,Bergquist D.Randomized clinical trial of routine preoperative duplex imaging before varicose vein surgery.Br J Surg. 2005;92:688-94.
109. Coleridge-Smith P,Labropoulos N,Partsch H,Myers K,Nicolaides A,Cavezzi A.Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs - UIP consensus document. Part I. Basic principles.Eur J Vasc Endovasc Surg. 2006;31:83-92.
110. De Maeseneer M,Pichot O,Cavezzi Aet al.Duplex ultrasound investigation of the veins of the lower limbs after treatment for varicose veins - UIP consensus document.Eur J Vasc Endovasc Surg. 2011;42:89-102.
111. Rautio T,Perala J,Biancari Fet al.Accuracy of hand-held Doppler in planning the operation for primary varicose veins.Eur J Vasc Endovasc Surg. 2002;24:450-5.
112. Franco G.Explorations ultrasonographiques des récidives variqueuses post-chirurgicales.Phlébologie. 1998;51:403-13.
113. Jiang P,van Rij AM,Christie R,Hill G,Solomon C,Thomson I.Recurrent varicose veins: patterns of reflux and clinical severity.Cardiovasc Surg. 1999;7:332-9.
114. Lee BB,Do YS,Byun HS,Choo IW,Kim DI,Huh SH.Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.J Vasc Surg. 2003;37:533-8.
115. Bihari I,Tasnadi G,Bihari P.Importance of subfascial collaterals in deep-vein malformations.Dermatol Surg. 2003;29:146-9.
116. Brunken A,Rabe E,Pannier F.Changes in venous function after foam sclerotherapy of varicose veins.Phlebology. 2009;24:145-50.
117. Darvall KAL,Sam RC,Bate GR,Adam DJ,Bradbury AW.Photoplethysmographic venous refilling times following ultrasound guided foam sclerotherapy for symptomatic superficial venous reflux: relationship with clinical outcomes.EJVES. 2010;40:267-72.
118. Kreussler: Fachinformationen Aethoxysklerol 0,25%/0,5%/1%/2%/3% Stand Oktober 2009, Chemische Fabrik Kreussler & Co GmbH.
119. STD Pharmaceutical Products Ltd. Prescribing Information, March 2012.
120. Kanter A,Thibault P.Saphenofemoral incompetence treated by ultrasound-guided sclerotherapy.Dermatol Surg. 1996;22:648-52.
121. Grondin L,Young R,Wouters L.Sclérothérapie écho-guidée et sécurité: Comparaison des techniques.Phlebologie. 1997;50:241-5.
122. Schadeck M,Allaert FA.Résultats à long terme de la Sclérothérapie des Saphènes internes.Phlébologie. 1997;50:257-262.
123. Wollmann JC.The history of sclerosing foams.Dermatol Surg. 2004;30:694-703.
124. Sadoun S,Benigni JP,Sica M.Étude prospective de l′efficacité de la mousse de sclérosant dans le traitement des varices tronculaires des membres inférieurs.Phlébologie. 2002;55:259-62.
125. Tessari L,Cavezzi A,Frullini A.Preliminary experience with a new sclerosing foam in the treatment of varicose veins.Dermatol Surg. 2001;27:58-60.
126. De Roos KP,Groen L,Leenders AC.Foam sclerotherapy: investigating the need for sterile air.Dermatol Surg. 2011;37:1119-24.
127. Guex JJ,Hamel-Desnos C,Gillet JL,Chleir F,Perrin M.Sclérothérapie des varices par mousse écho-guidée: techniques de mise en œuvre, indications, résultats publiés.Phlébologie. 2008;61:261-70.
128. Yamaki T,Hamahata A,Soejima K,Kono T,Nozaki M,Sakurai H.Prospective randomised comparative study of visual foam sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report.EJVES. 2012;43:343-7.
129. Ceulen RPM,Bullens-Goessens YIJM,Pi-Van De Venne SJA.Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% Polidocanol foam: results of a randomized controlled trial with 1-year follow-up.Dermatol Surg. 2007;33:276-81.
130. Brodersen JP.Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter.Dermatol Surg. 2007;33:469-75.
131. Yamaki T,Nozaki M,Iwasaka S.Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.Dermatol Surg. 2004;30:718-22.
132. Kern P,Ramelet AA,Wütschert R,Hayoz D.Compression after sclerotherapy for telangiectasiastelangiectasias and reticular leg veins. A randomized controlled study.J Vasc Surg. 2007;45:1212-6.
133. Ceulen RPM,Jagtmann EA,Sommer A,Teule GJJ,Schurink GWH,Kemerink GJ.Blocking the saphenafemoral junction during ultrasound guided foam sclerotherapy - assessment of a presumed safety-measure procedure.Eur J Vasc Endovasc Surg. 2010;40:772-6.
134. Wildenhues B.Catheter-assisted foam sclerotherapy: a new minimally invasive method for the treatment of trunk varicosis of the long and short saphenous veins.Phlebologie. 2005;34:165-70.
135. Hahn M,Schulz T,Jünger M.Sonographically guided, transcatheter foam sclerotherapy of the great saphenous vein. Medical and economic aspects.Phlebologie. 2007;36:309-12.
136. Bidwai A,Beresford T,Dialynas M,Prionidis J,Panayiotopoulos Y,Bowne TF.Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation.J Vasc Surg. 2007;46:145-7.
137. Kölbel T,Hinchliffe RJ,Lindbal B.Catheter-directed foam sclerotherapy of axial saphenous reflux.Early results. Phlebology. 2007;22:219-22.
138. Parsi K.Catheter-directed sclerotherapy.Phlebology. 2009;24:98-107.
139. Cavezzi A,Tessari L.Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection.Phlebology. 2009;24:247-51.
140. Blaise S,Bosson JL,Diamand JM.Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up.Eur J Vasc Endovasc Surg. 2010;39:779-86.
141. Chapman-Smith P,Browne A.Prospective five year study of ultrasound guided foam sclerotherapy in the treatment of great saphenous vein reflux.Phlebology. 2009;24:183-8.
142. Weiss RA,Sadick NS,Goldman MP,Weiss MA.Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome.Dermatol Surg. 1999;25:105-8.
143. Goldman PM,Beaudoing D,Marley Wet al.Compression in the treatment of leg teleangiectasia: a preliminary report.J Dermatol Surg Oncol. 1990;16:322-5.
144. Nootheti PK,Cadag KM,Magpantay A,Goldman MP.Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins.Dermatol Surg. 2009;35:53-8.
145. Hamel-Desnos C,Guias BJ,Desnos PR,Mesgard A.Foam sclerotherapy of the saphenous veins. Randomised controlled trial with or without compression.Eur J Vasc Endovasc Surg. 2010;39:500-7.
146. Zarca C,Bailly C,Gachet G,Spini L.ClassMousse 1 study: compression hosiery and foam sclerotherapy.Phlébologie. 2012;65:11-20.
147. Ferrara F,Bernbach HR.La compression écho-guidée après sclérothérapie.Phlébologie. 2009;62:36-41.
148. Stanley PRW,Bickerton DR,Campbell WB.Injection sclerotherapy for varicose veins - a comparison of materials for applying local compression.Phlebology. 1991;6:37-9.